Literature DB >> 24090944

Liver abnormalities in drug and substance abusers.

Puraskar Pateria1, Bastiaan de Boer, Gerry MacQuillan.   

Abstract

Drug and substance abuse remains a major medical problem. Alcohol use, abuse and dependence are highly prevalent conditions. Alcohol related liver disease can present as simple steatosis, steatohepatitis, alcoholic hepatitis or liver cirrhosis. Paracetamol hepatotoxicity secondary to accidental or deliberate overdose is another common problem. While the adverse cardiovascular, neurological, renal and psychiatric consequences of various illicit substance abuses are widely studied and publicized, less attention has been directed towards possible hepatotoxic effects. Illicit drug abuse can cause a range of liver abnormalities ranging from asymptomatic derangement of liver function tests to fulminant hepatic failure. This article reviews the epidemiology, risk factors, clinical manifestations, pathogenesis, investigations, management and prognostic factors of alcohol related liver disease and paracetamol hepatotoxicity as well as the current knowledge pertaining to hepatotoxicity of the more commonly used illicit substances including cannabis, amphetamine type stimulants, cocaine, khat chewing and complementary and alternate medicine. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol steatosis; Alcoholic hepatitis; Amphetamine; Cannabis; Cirrhosis; Cocaine; Complementary and alternative medicine; Khat

Mesh:

Substances:

Year:  2013        PMID: 24090944     DOI: 10.1016/j.bpg.2013.08.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  14 in total

Review 1.  Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease.

Authors:  Fernando Ezquer; Flavia Bruna; Sebastián Calligaris; Paulette Conget; Marcelo Ezquer
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Therapy for alcoholic liver disease.

Authors:  Maryconi M Jaurigue; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 3.  Role of mitochondria in alcoholic liver disease.

Authors:  Fatiha Nassir; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

4.  Acceleration of cardiovascular-biological age by amphetamine exposure is a power function of chronological age.

Authors:  Albert Stuart Reece; Amanda Norman; Gary Kenneth Hulse
Journal:  Heart Asia       Date:  2017-01-10

Review 5.  Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond.

Authors:  Ruizhi Gu; Alina Liang; Grace Liao; Isabelle To; Amina Shehu; Xiaochao Ma
Journal:  Drug Metab Dispos       Date:  2022-02-27       Impact factor: 3.579

6.  Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIV.

Authors:  Javier A Tamargo; Kenneth E Sherman; Rafick-Pierre Sékaly; Rebeka Bordi; Daniela Schlatzer; Shenghan Lai; Jag H Khalsa; Raul N Mandler; Richard L Ehman; Marianna K Baum
Journal:  Drug Alcohol Depend       Date:  2022-01-12       Impact factor: 4.852

7.  Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV.

Authors:  Javier A Tamargo; Kenneth E Sherman; Adriana Campa; Sabrina S Martinez; Tan Li; Jacqueline Hernandez; Colby Teeman; Raul N Mandler; Jun Chen; Richard L Ehman; Marianna K Baum
Journal:  Am J Clin Nutr       Date:  2021-03-11       Impact factor: 8.472

8.  Establishment of the tree shrew as an alcohol-induced Fatty liver model for the study of alcoholic liver diseases.

Authors:  Huijie Xing; Kun Jia; Jun He; Changzheng Shi; Meixia Fang; Linliang Song; Pu Zhang; Yue Zhao; Jiangnan Fu; Shoujun Li
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

9.  Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine.

Authors:  Luciano Rezende Vilela; Lindisley Ferreira Gomides; Bruna Araújo David; Maísa Mota Antunes; Ariane Barros Diniz; Fabrício de Araújo Moreira; Gustavo Batista Menezes
Journal:  Mediators Inflamm       Date:  2015-04-27       Impact factor: 4.711

Review 10.  Molecular mechanisms of liver fibrosis in HIV/HCV coinfection.

Authors:  Claudio M Mastroianni; Miriam Lichtner; Claudia Mascia; Paola Zuccalà; Vincenzo Vullo
Journal:  Int J Mol Sci       Date:  2014-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.